Le cerveau multidimensionnel

Accueil du site Neuro-PSI > Animation scientifique

Neuro-PSI Conference on May 18th

On Friday, May 18th at 11:00, Dr Jevgenij Raskatov, Department of Chemistry and Biochemistry, University of California Santa Cruz, USA, will give a talk on this following topic
« Chirality, Alzheimer’s Disease and Amyloid beta. »

- raskatov.chemistry.ucsc.edu

Invited by Ronald Melki
- See the pdf

Chirality, Alzheimer’s Disease and Amyloid Beta. Jevgenij A. Raskatova,*
a Department of Chemistry and Biochemistry, Physical Science Building 356, 1156 High Street, University of California Santa Cruz, Santa Cruz, CA 95064, USA
* Correspondence should be addressed to : jraskato[At]ucsc.edu

Chirality is of paramount importance to all living systems.
It is a property of all principal biomolecular building blocks, i.e., amino acids except glycine, sugars and nucleosides, as well as lipids. Continuous improvement of preparative methodologies allows increasingly complex molecules to be synthesized, which includes sophisticated mirror-image biomolecules (e.g., full-length proteins).[1]
Aggregation-prone (amyloidogenic) polypeptides are produced by living systems, often as cleavage products of substantially larger protein precursors. Whereas their functions in health are challenging to study and not always well understood, it is widely accepted that an imbalance between their production and clearance can trigger a range of pathological conditions, including Alzheimer’s Disease (AD / amyloid β, Aβ), Huntington’s Disease (HD / the huntingtin protein) and Type 2 Diabetes (T2D / amylin).[2] A feature that is common to all those peptides is the high polydispersity across both aggregate size and shape, with distinctions frequently made between oligomers, protofibrils and fibrils.[3] In sporadic AD, Aβ oligomers (especially those derived from the 42-amino acid long isoform, Aβ42) are believed to be particularly harmful, whereas fibrils appear to represent an aggregation endpoint that may be relatively benign.[4]
Peptide backbone conformations can be altered through introduction of D-amino acids (“Chiral Editing”),[5] and replacement of L- by D-amino acids across the entire peptide yields mirror image (“D-“)Aβ. Because of the enantiomeric relation, D-Aβ has to possess an identical oligomer-protofibril-fibril distribution to that of the natural (“L-“) stereoisomer. However, all 3D-structural parameters are mirrored in D-Aβ42, including the peptide backbone. We synthesized the two enantiomers of Aβ42 and found that their equimolar mixture exhibited pronounced acceleration of fibril formation, as compared to the enantiopure counterparts. This led to substantial suppression of oligomer formation and inhibition of toxicity in model cell-based systems. We termed this approach “Chiral Inactivation”.[6] The underlying molecular mechanisms that lead to the differences in biophysical and biological properties observed between enantiopure and racemic Aβ42 remain subject of active research in our laboratory.


[1] S. B. H. Kent, Chem. Soc. Rev. 2009, 38, 338-351.
[2] F. Chiti and C. M. Dobson, Annu. Rev. Biochem. 2006, 75, 333-366.
[3] D. B. Teplow, Alzheimer’s Res. Ther. 2013, 5.
[4] a) C. Haass and D. J. Selkoe, Nature Reviews Molecular Cell Biology 2007, 8, 101-112 ; b) D. J. Selkoe, Nat. Med. 2011, 17, 1060-1065.
[5] a) J. A. Raskatov and D. B. Teplow, Sci. Rep. 2017, DOI : 10.1038/s41598-017-10525-5 ; b) C. J. A. Warner, S. Dutta, A. R. Foley and J. A. Raskatov, Chem. Eur. J. 2016, 22, 11967-11970.
[6] S. Dutta, A. R. Foley, C. J. A. Warner, X. Zhang, M. Rolandi, B. Abrams and J. A. Raskatov, Angew. Chem. Int. Ed. 2017, DOI : 10.1002/anie.201706279.

  Webmaster Plan du site Planning Crédits
Syndication RSS  
  Format Mobiles
  Dev-Evo Cog-Comp Mol-Circ